Cargando…
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics
BACKGROUND: Pregnane X receptor (PXR) agonists inhibit liver fibrosis. However, the rodent PXR activator pregnenolone 16α carbonitrile (PCN) blocks, in vitro, hepatic stellate cell-to-myofibroblast trans-differentiation and proliferation in cells from mice with a disrupted PXR gene, suggesting there...
Autores principales: | Marek, Carylyn J, Wallace, Karen, Durward, Elaine, Koruth, Matthew, Leel, Val, Leiper, Lucy J, Wright, Matthew C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688476/ https://www.ncbi.nlm.nih.gov/pubmed/19432992 http://dx.doi.org/10.1186/1476-5926-8-1 |
Ejemplares similares
-
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy
por: Douglass, Angela, et al.
Publicado: (2008) -
Inflammation Writes the Fibrogenic Code
por: Friedersdorf, Matthew, et al.
Publicado: (2021) -
Reduced S-nitrosylation of TGFβ1 elevates its binding affinity towards the receptor and promotes fibrogenic signaling in the breast
por: Letson, Joshua, et al.
Publicado: (2023) -
PSnpBind-ML: predicting the effect of binding site mutations on protein-ligand binding affinity
por: Ammar, Ammar, et al.
Publicado: (2023) -
Label-Free Microscale Thermophoresis Discriminates Sites and Affinity of Protein–Ligand Binding**
por: Seidel, Susanne A I, et al.
Publicado: (2012)